CBD can mediate the cytotoxicity of human primary GBM stem-like cells (hGSCs) by promoting the DNA binding of NF-κB subunit RELA and simultaneously prevent RELA phosphorylation, suggesting that NF-κB can be converted into a tumor suppressor via non-psychotropic CBD [16]. This evidence concerns the gene NFKB1 and glioblastoma.